Pharma enzymes for biocatalysis and cell culture

Novozymes offers enzymes for biocatalysis and rTrypsin for cell culture. Enzymes offer benefits such as cost savings and improved productivity and quality.

Enzymes for biocatalysis
In biocatalysis, natural catalysts - such as enzymes – are used in place of chemical catalysts in synthetic processes, opening more cost-effective and sustainable routes for the production of intermediates and active pharmaceutical ingredients (APIs). Enzymes offer a range of benefits as biocatalysts in organic transformations, including:
  • Cost savings
  • Improved productivity
  • Improved quality of API/intermediate
  • Environmental friendliness
Novozymes’ product portfolio includes lipases, immobilized lipases, and proteases for biocatalysis. Find out more
Enzymes for cell culture
Various biotechnological processes such as tissue dissociation, cell harvesting and subculturing cells involve the use of trypsin. Novozymes rTrypsin is a recombinant product manufactured by microbial fermentation. rTrypsin is animal origin-free and manufactured to ISO 9001:2008 standards. rTrypsin for cell culture offers a range of benefits, including:
  • Elimination of risk of animal enzyme contaminants
  • Elimination of risk of viral and animal-related contaminants in the final product
  • Stability unaffected by Ca2+
  • Consistent supply

Read more... 

Contact Pharmaceuticals for further information

Novozymes does not promote or support the use of enzymes as Active Pharmaceutical Ingredients (APIs) or excipients. Enzymes are not produced according to pharmaceutical standards. If enzymes are used as process aids, it is the responsibility of the API/excipient manufacturer to assure that the enzymes are suitable for the intended use, including but not limited to evaluation of purity and absence in the final product.
Laws, regulations and/or third party rights may prevent customers from importing, using, processing and/or reselling the products described herein in a given manner. Without separate, written agreement between the customer and Novozymes to such effect, the information provided does not constitute a representation or warranty of any kind and is subject to change without further notice.